Find therapies in clinical trials near you – page 76

Study on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome

Study on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome

Study of Favezelimab Combined with Pembrolizumab (MK-4280A) for Patients with Selected Solid Tumors

Study of Favezelimab Combined with Pembrolizumab (MK-4280A) for Patients with Selected Solid Tumors

Study of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery

Study of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery

Study on the Effectiveness and Safety of BAY 3018250 and Low Molecular Weight Heparin for Patients with Proximal Deep Vein Thrombosis

Study on the Effectiveness and Safety of BAY 3018250 and Low Molecular Weight Heparin for Patients with Proximal Deep Vein Thrombosis

Study on the Safety and Effectiveness of GEN3017 for Patients with Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma

Study of XPro1595 for Patients with Early Alzheimer's Disease and Inflammation Markers

Study of XPro1595 for Patients with Early Alzheimer's Disease and Inflammation Markers

Study of Ravulizumab for Children with Thrombotic Microangiopathy After Stem Cell Transplant

Study on Seralutinib for Treating Pulmonary Arterial Hypertension in Patients

Study on Seralutinib for Treating Pulmonary Arterial Hypertension in Patients

Study of Immunotherapy Combinations Including Zimberelimab for Patients With Advanced Non-Small Cell Lung Cancer

Study of Immunotherapy Combinations Including Zimberelimab for Patients With Advanced Non-Small Cell Lung Cancer

Study of Zipalertinib with Chemotherapy vs. Chemotherapy Alone for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Study of Zipalertinib with Chemotherapy vs. Chemotherapy Alone for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Study on Lutetium (177Lu) Vipivotide Tetraxetan and Androgen Receptor Inhibitors for Patients with Castration-Resistant Prostate Cancer

Study on Lutetium (177Lu) Vipivotide Tetraxetan and Androgen Receptor Inhibitors for Patients with Castration-Resistant Prostate Cancer

Study Comparing Tisotumab Vedotin with Chemotherapy for Patients with Recurrent or Metastatic Cervical Cancer

Study Comparing Tisotumab Vedotin with Chemotherapy for Patients with Recurrent or Metastatic Cervical Cancer